Three-dimensional (3D) in vivo cell culture modeling is quickly emerging as a platform to replace two-dimensional (2D) monolayer cell culture in vitro tests. Three-dimensional tumor models mimic physiological conditions and provide valuable insight of the tumor cell response to drug discovery application. In this study, we used poly(ethylene glycol) (PEG) hydrogel microwells to generate 3D brain cancer spheroids and studied their treatment with anticancer drugs in single or combination treatment. Glioblastoma (GBM) spheroids were grown through 14 days before infecting with two drugs: Pitavastatin and Irinotecan at various concentrations. A significant cell lysis was observed and cell viability decreased to lower than 7% when drugs were combined at the concentration Pitavastatin 10 μM and Irinotecan 50 μM to infect after 7 days. These findings demonstrate a promising platform—PEG hydrogel microwells—that should be an efficient way to test the drug sensitivity in vitro as well as application in different studies.
Issue Section:
Engineering Cell Microenvironment Using Novel Hydrogels
Keywords:
Biomedical
References
1.
Sun
, X.
, Vila
, S.
, and Tatonetti
, N. P.
, 2013
, “High-Throughput Methods for Combinatorial Drug Discovery
,” Sci. Transl. Med.
, 5
(205
), p. 205rv1
.2.
Jiang
, P.
, Mukthavaram
, R.
, and Chao
, Y.
, 2014
, “Novel Anti-Glioblastoma Agents and Therapeutic Combinations Identified From a Collection of FDA Approved Drugs
,” J. Transl. Med.
, 12
(13
).3.
Huh
, D.
, Hamilton
, G. A.
, and Ingber
, D. E.
, 2011
, “From Three-Dimensional Cell Culture to Organs-on-Chips
,” Trends Cell Biol.
, 21
(12
), pp. 745
–754
.4.
Elliott
, N. T.
, and Yuan
, F.
, 2011
, “A Review of Three-Dimensional In Vitro Tissue Models for Drug Discovery and Transport Studies
,” J. Pharm. Sci.
, 100
(1
), pp. 59
–74
.5.
Imamura
, Y.
, Mukohara
, T.
, Shimono
, Y.
, Funakoshi
, Y.
, Chayahara
, N.
, Toyoda
, M.
, Kiyota
, N.
, Takao
, S.
, Kono
, S.
, Nakatsura
, T.
, and Minami
, H.
, 2015
, “Comparison of 2D- and 3D-Culture Models as Drug-Testing Platforms in Breast Cancer
,” Oncol. Rep.
, 33
(4
), pp. 1837
–1843
.6.
Griffith
, L. G.
, and Swartz
, M. A.
, 2006
, “Capturing Complex 3D Tissue Physiology In Vitro
,” Nat. Rev. Mol. Cell Biol.
, 7
(3
), pp. 211
–224
.7.
Yamada
, K. M.
, and Cukierman
, E.
, 2007
, “Modeling Tissue Morpho- Genesis and Cancer in 3D
,” Cell
, 130
(4
), pp. 601
–610
.8.
Pampaloni
, F.
, Reynaud
, E. G.
, and Stelzer
, E. H. K.
, 2007
, “The Third Dimension Bridges the Gap Between Cell Culture and Live Tissue
,” Nat. Rev. Mol. Cell Biol.
, 8
(10
), pp. 839
–845
.9.
Breslin
, S.
, and O'Driscoll
, L.
, 2013
, “Three-Dimensional Cell Culture: The Missing Link in Drug Discovery
,” Drug Discovery Today
, 18
(5–6), pp. 240
–249
.10.
Edmondson
, R.
, Broglie
, J. J.
, Adcock
, A. F.
, and Yang
, 2014
, “Three-Dimensional Cell Culture Systems and Their Applications in Drug Discovery and Cell-Based Biosensors
,” Assay Drug Dev. Technol.
, 12
(4
), pp. 207
–218
.11.
Tung
, Y. C.
, Hsiao
, A. Y.
, Allen
, S. G.
, Torisawa
, Y. S.
, Ho
, M.
, and Takayama
, S.
, 2011
, “High-Throughput 3D Spheroid Culture and Drug Testing Using a 384 Hanging Drop Array
,” The Analyst
, 136
(3
), pp. 473
–478
.12.
Thoma
, C. R.
, Stroebel
, S.
, Rösch
, N.
, Calpe
, B.
, Krek
, W.
, and Kelm
, J. M.
, 2013
, “A High-Throughput-Compatible 3D Microtissue Co-Culture System for Phenotypic RNAi Screening Applications
,” J. Biomol. Screening
, 18
(10
), pp. 1330
–1337
.13.
Moeller
, H. C.
, Mian
, M. K.
, Shrivastava
, S.
, Ching
, B. G.
, and Khademhosseini
, A.
, 2008
, “A Microwell Array System for Stem Cell Culture
,” Biomaterials
, 29
(6
), pp. 752
–763
.14.
Selimovic
, S.
, Piraino
, F.
, Bae
, H.
, Rasponi
, M.
, Redaelli
, A.
, and Khademhosseini
, A.
, 2011
, “Microfabricated Polyester Conical Microwells for Cell Culture Applications
,” Lab Chip
, 11
(14
), pp. 2325
–2332
.15.
Hsieh
, C. H.
, Wang
, J. L.
, and Huang
, Y. Y.
, 2011
, “Large-Scale Cultivation of Transplantable Dermal Papilla Cellular Aggregates Using Microfabricated PDMS Arrays
,” Acta Biomater.
, 7
(1
), pp. 315
–324
.16.
Khademhosseini
, A.
, Yeh
, J.
, Eng
, G.
, Karp
, J.
, Kaji
, H.
, Borenstein
, J.
, Farokhzad
, O. C.
, and Langer
, R.
, 2011
, “Cell Docking Inside Microwells Within Reversibly Sealed Microfluidic Channels
,” Lab Chip
, 11
(1
), pp. 115
–119
.17.
Fan
, Y.
, Avci
, N. G.
, Nguyen
, D. T.
, Dragomir
, A.
, Akay
, Y. M.
, Xu
, F.
, and Akay
, M.
, 2015
, “Engineering a High-Throughput 3D In Vitro Glioblastoma Model
,” IEEE J. Transl. Eng. Health Med
., 3
, Article No. 4300108.18.
Yasuda
, Y.
, Shimizu
, M.
, Shirakami
, Y.
, Sakai
, H.
, Kubota
, M.
, Hata
, K.
, Hirose
, Y.
, Tsurumi
, H.
, Tanaka
, T.
, and Moriwaki
, H.
, 2010
, “Pitavastatin Inhibits Azoxymethane-Induced Colonic Preneoplastic Lesions in C57BL/KsJ-db/db Obese Mice
,” Cancer Sci.
, 101
(7
), pp. 1701
–1707
.19.
Demierre
, M. F.
, Higgins
, P. D.
, Gruber
, S. B.
, Hawk
, E.
, and Lippman
, S. M.
, 2005
, “Statins and Cancer Prevention
,” Nat. Rev. Cancer
, 5
(12
), pp. 930
–942
.20.
Yanae
, M.
, Tsubaki
, M.
, Satou
, T.
, Itoh
, T.
, Imano
, M.
, Yamazoe
, Y.
, and Nishida
, S.
, 2011
, “Statin-Induced Apoptosis Via the Suppression of ERK1/2 and Akt Activation by Inhibition of the Geranylgeranyl-Pyrophosphate Biosynthesis in Glioblastoma
,” J. Exp. Clin. Cancer Res.
, 30
(1
), p. 74
.21.
Gauthaman
, K.
, Fong
, C. Y.
, and Bongso
, A.
, 2009
, “Statins, Stem Cells, and Cancer
,” J. Cell. Biochem.
, 106
(6
), pp. 975
–983
.22.
Cho
, S. J.
, Kim
, J. S.
, Kim
, J. M.
, Lee
, J. Y.
, Jung
, H. C.
, and Song
, I. S.
, 2008
, “Simvastatin Induces Apoptosis in Human Colon Cancer Cells and in Tumor Xenografts, and Attenuates Colitis-Associated Colon Cancer in Mice
,” Int. J. Cancer
, 123
(4
), pp. 951
–957
.23.
Vredenburgh
, J. J.
, Desjardins
, A.
, Reardon
, D. A.
, and Friedman
, H. S.
, 2009
, “Experience With Irinotecan for the Treatment of Malignant Glioma
,” Neuro-Oncology
, 11
, pp. 80
–91
.24.
Cloughesy
, T. F.
, Filka
, E.
, Nelson
, G.
, Kabbinavar
, F.
, Friedman
, H.
, Miller
, L. L.
, and Elfring
, G. L.
, 2002
, “Irinotecan Treatment for Recurrent Malignant Glioma Using an Every-3-Week Regimen
,” Am. J. Clin. Oncol.
, 25
(2
), pp. 204
–208
.25.
Wang
, Y.
, Tang
, L.
, Li
, Z.
, Lin
, Y.
, and Li
, J.
, 2014
, “In Situ Simultaneous Monitoring of ATP and GTP Using a Graphene Oxide Nanosheet-Based Sensing Platform in Living Cells
,” Nat. Protoc.
, 9
(8
), pp. 1944
–1955
.26.
Strober
, W.
, 2001
, “APPENDIX 3B Trypan Blue Exclusion Test of Cell Viability
,” Curr. Protoc. Immunol
.27.
Chamberlin
, K. W.
, and Baker
, W. L.
, 2015
, “Benefit–Risk Assessment of Pitavastatin for the Treatment of Hypercholesterolemia in Older Patients
,” Clin. Interventions Aging
, 10
, pp. 733
–740
.28.
Adkins
, C. E.
, Nounou
, M. I.
, Hye
, T.
, Mohammad
, A. S.
, Terrell-Hall
, T.
, Mohan
, N. K.
, Eldon
, M. A.
, Hoch
, U.
, and Lockman
, P. R.
, 2015
, “NKTR-102 Efficacy Versus Irinotecan in a Mouse Model of Brain Metastases of Breast Cancer
,” BMC Cancer
, 15
(1
), pp. 685
–696
.29.
Tsuboi
, Y.
, Kurimoto
, M.
, Nagai
, S.
, Hayakawa
, Y.
, Kamiyama
, H.
, Hayashi
, N.
, Kitajima
, I.
, and Endo
, S.
, 2009
, “Induction of Autophagic Cell Death and Radiosensitization by the Pharmacological Inhibition of Nuclear Factor-Kappa B Activation in Human Glioma Cell Lines
,” J. Neurosurg.
, 110
(3
), pp. 594
–604
.Copyright © 2016 by ASME
You do not currently have access to this content.
